# Sanfilippo John B & Son Inc: financial statements, quarterly

JBSS · Nasdaq · CIK 880117 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 28

Pages: [Overview](/companies/jbss.md) · [Financials](/companies/jbss/financials.md) · [Filings](/companies/jbss/filings.md) · [Insiders](/companies/jbss/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jbss/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-28) | Q3 FY2024 (2024-03-28) | Q4 FY2024 (2024-06-27) | Q1 FY2025 (2024-09-26) | Q2 FY2025 (2024-12-26) | Q3 FY2025 (2025-03-27) | Q4 FY2025 (2025-06-26) | Q1 FY2026 (2025-09-25) | Q2 FY2026 (2025-12-25) | Q3 FY2026 (2026-03-26) | Q4 FY2026 (2026-06-25) | Q1 FY2027 (2026-09-24) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [291](/filings/0000950170-25-010565.md) | [272](/filings/0000950170-25-061074.md) | [270 d](/filings/0001193125-26-356919.md) | [276](/filings/0001193125-25-256406.md) | [301](/filings/0001193125-26-029438.md) | [261](/filings/0001193125-26-191644.md) | [269 d](/filings/0001193125-26-356919.md) | [299](/filings/0001193125-26-436164.md) | [315](/filings/0001193125-26-029438.md) | [282](/filings/0001193125-26-191644.md) | [280 d](/filings/0001193125-26-356919.md) | [288](/filings/0001193125-26-436164.md) |
| Cost of revenue | $m | [233](/filings/0000950170-25-010565.md) | [223](/filings/0000950170-25-061074.md) | [220 d](/filings/0001193125-26-356919.md) | [230](/filings/0001193125-25-256406.md) | [249](/filings/0001193125-26-029438.md) | [205](/filings/0001193125-26-191644.md) | [220 d](/filings/0001193125-26-356919.md) | [245](/filings/0001193125-26-436164.md) | [256](/filings/0001193125-26-029438.md) | [228](/filings/0001193125-26-191644.md) | [236 d](/filings/0001193125-26-356919.md) | [239](/filings/0001193125-26-436164.md) |
| Gross profit | $m | [57.9](/filings/0000950170-25-010565.md) | [49.2](/filings/0000950170-25-061074.md) | [50.0 d](/filings/0001193125-26-356919.md) | [46.5](/filings/0001193125-25-256406.md) | [52.3](/filings/0001193125-26-029438.md) | [55.9](/filings/0001193125-26-191644.md) | [48.8 d](/filings/0001193125-26-356919.md) | [54.1](/filings/0001193125-26-436164.md) | [59.2](/filings/0001193125-26-029438.md) | [53.8](/filings/0001193125-26-191644.md) | [44.1 d](/filings/0001193125-26-356919.md) | [48.9](/filings/0001193125-26-436164.md) |
| Operating income | $m | [27.6](/filings/0000950170-25-010565.md) | [18.4](/filings/0000950170-25-061074.md) | [14.7 d](/filings/0001193125-26-356919.md) | [17.0](/filings/0001193125-25-256406.md) | [19.4](/filings/0001193125-26-029438.md) | [28.2](/filings/0001193125-26-191644.md) | [20.1 d](/filings/0001193125-26-356919.md) | [27.0](/filings/0001193125-26-436164.md) | [26.0](/filings/0001193125-26-029438.md) | [23.8](/filings/0001193125-26-191644.md) | [12.4 d](/filings/0001193125-26-356919.md) | [19.3](/filings/0001193125-26-436164.md) |
| Interest expense | $m | [1.1](/filings/0000950170-24-009840.md) | [0.8](/filings/0000950170-24-051300.md) | [0.5 d](/filings/0000950170-24-099489.md) | [0.5](/filings/0001193125-25-256406.md) | [0.8](/filings/0001193125-26-029438.md) | [1.1](/filings/0001193125-26-191644.md) | [1.2 d](/filings/0001193125-26-356919.md) | [1.0](/filings/0001193125-26-436164.md) | [0.5](/filings/0001193125-26-029438.md) | [0.5](/filings/0001193125-26-191644.md) | [0.4 d](/filings/0001193125-26-356919.md) | [0.7](/filings/0001193125-26-436164.md) |
| Income tax | $m | [6.8](/filings/0000950170-25-010565.md) | [3.4](/filings/0000950170-25-061074.md) | [3.5 d](/filings/0001193125-26-356919.md) | [4.1](/filings/0001193125-25-256406.md) | [4.3](/filings/0001193125-26-029438.md) | [6.0](/filings/0001193125-26-191644.md) | [4.6 d](/filings/0001193125-26-356919.md) | [6.3](/filings/0001193125-26-436164.md) | [6.6](/filings/0001193125-26-029438.md) | [5.4](/filings/0001193125-26-191644.md) | [2.7 d](/filings/0001193125-26-356919.md) | [4.4](/filings/0001193125-26-436164.md) |
| Net income | $m | [19.2](/filings/0000950170-25-061074.md) | [13.5](/filings/0000950170-25-061074.md) | [10.0 d](/filings/0001193125-26-356919.md) | [11.7](/filings/0001193125-26-191644.md) | [13.6](/filings/0001193125-26-191644.md) | [20.2](/filings/0001193125-26-191644.md) | [13.5 d](/filings/0001193125-26-356919.md) | [18.7](/filings/0001193125-26-436164.md) | [18.0](/filings/0001193125-26-191644.md) | [16.8](/filings/0001193125-26-191644.md) | [8.4 d](/filings/0001193125-26-356919.md) | [13.2](/filings/0001193125-26-436164.md) |
| Diluted EPS | $ per share | [1.64](/filings/0000950170-25-010565.md) | [1.15](/filings/0000950170-25-061074.md) | not reported | [1.00](/filings/0001193125-25-256406.md) | [1.16](/filings/0001193125-26-029438.md) | [1.72](/filings/0001193125-26-191644.md) | not reported | [1.59](/filings/0001193125-26-436164.md) | [1.53](/filings/0001193125-26-029438.md) | [1.43](/filings/0001193125-26-191644.md) | not reported | [1.11](/filings/0001193125-26-436164.md) |
| Basic EPS | $ per share | [1.65](/filings/0000950170-25-010565.md) | [1.16](/filings/0000950170-25-061074.md) | not reported | [1.00](/filings/0001193125-25-256406.md) | [1.17](/filings/0001193125-26-029438.md) | [1.73](/filings/0001193125-26-191644.md) | not reported | [1.60](/filings/0001193125-26-436164.md) | [1.54](/filings/0001193125-26-029438.md) | [1.44](/filings/0001193125-26-191644.md) | not reported | [1.12](/filings/0001193125-26-436164.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-28) | Q3 FY2024 (2024-03-28) | FY2024 (2024-06-27) | Q1 FY2025 (2024-09-26) | Q2 FY2025 (2024-12-26) | Q3 FY2025 (2025-03-27) | FY2025 (2025-06-26) | Q1 FY2026 (2025-09-25) | Q2 FY2026 (2025-12-25) | Q3 FY2026 (2026-03-26) | FY2026 (2026-06-25) | Q1 FY2027 (2026-09-24) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.0](/filings/0000950170-25-010565.md) | [0.4](/filings/0000950170-25-061074.md) | [0.5](/filings/0000950170-25-110463.md) | [0.4](/filings/0001193125-25-256406.md) | [0.3](/filings/0001193125-26-029438.md) | [1.3](/filings/0001193125-26-191644.md) | [0.6](/filings/0001193125-26-356919.md) | [0.7](/filings/0001193125-26-436164.md) | [2.4](/filings/0001193125-26-029438.md) | [1.3](/filings/0001193125-26-191644.md) | [1.1](/filings/0001193125-26-436164.md) | [2.0](/filings/0001193125-26-436164.md) |
| Current assets | $m | [290](/filings/0000950170-25-010565.md) | [296](/filings/0000950170-25-061074.md) | [294](/filings/0000950170-25-110463.md) | [287](/filings/0001193125-25-256406.md) | [307](/filings/0001193125-26-029438.md) | [349](/filings/0001193125-26-191644.md) | [346](/filings/0001193125-26-356919.md) | [334](/filings/0001193125-26-436164.md) | [337](/filings/0001193125-26-029438.md) | [352](/filings/0001193125-26-191644.md) | [349](/filings/0001193125-26-436164.md) | [339](/filings/0001193125-26-436164.md) |
| Total assets | $m | [484](/filings/0000950170-25-010565.md) | [492](/filings/0000950170-25-061074.md) | [516](/filings/0000950170-25-110463.md) | [519](/filings/0001193125-25-256406.md) | [545](/filings/0001193125-26-029438.md) | [590](/filings/0001193125-26-191644.md) | [598](/filings/0001193125-26-356919.md) | [599](/filings/0001193125-26-436164.md) | [618](/filings/0001193125-26-029438.md) | [651](/filings/0001193125-26-191644.md) | [659](/filings/0001193125-26-436164.md) | [673](/filings/0001193125-26-436164.md) |
| Current liabilities | $m | [128](/filings/0000950170-25-010565.md) | [120](/filings/0000950170-25-061074.md) | [126](/filings/0000950170-25-110463.md) | [140](/filings/0001193125-25-256406.md) | [150](/filings/0001193125-26-029438.md) | [174](/filings/0001193125-26-191644.md) | [156](/filings/0001193125-26-356919.md) | [137](/filings/0001193125-26-436164.md) | [148](/filings/0001193125-26-029438.md) | [153](/filings/0001193125-26-191644.md) | [168](/filings/0001193125-26-436164.md) | [173](/filings/0001193125-26-436164.md) |
| Total liabilities | $m | [177](/filings/0000950170-25-010565.md) | [170](/filings/0000950170-25-061074.md) | [193](/filings/0000950170-25-110463.md) | [209](/filings/0001193125-25-256406.md) | [220](/filings/0001193125-26-029438.md) | [243](/filings/0001193125-26-191644.md) | [237](/filings/0001193125-26-356919.md) | [236](/filings/0001193125-26-436164.md) | [248](/filings/0001193125-26-029438.md) | [263](/filings/0001193125-26-191644.md) | [279](/filings/0001193125-26-436164.md) | [302](/filings/0001193125-26-436164.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [307](/filings/0000950170-25-061074.md) | [322](/filings/0000950170-25-061074.md) | [323](/filings/0001193125-26-356919.md) | [311](/filings/0001193125-26-191644.md) | [326](/filings/0001193125-26-191644.md) | [347](/filings/0001193125-26-191644.md) | [361](/filings/0001193125-26-436164.md) | [363](/filings/0001193125-26-436164.md) | [370](/filings/0001193125-26-191644.md) | [388](/filings/0001193125-26-191644.md) | [380](/filings/0001193125-26-436164.md) | [371](/filings/0001193125-26-436164.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-28) | Q3 FY2024 (2024-03-28) | Q4 FY2024 (2024-06-27) | Q1 FY2025 (2024-09-26) | Q2 FY2025 (2024-12-26) | Q3 FY2025 (2025-03-27) | Q4 FY2025 (2025-06-26) | Q1 FY2026 (2025-09-25) | Q2 FY2026 (2025-12-25) | Q3 FY2026 (2026-03-26) | Q4 FY2026 (2026-06-25) | Q1 FY2027 (2026-09-24) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.3 d](/filings/0000950170-25-010565.md) | [5.3 d](/filings/0000950170-25-061074.md) | [35.2 d](/filings/0001193125-26-356919.md) | [8.9](/filings/0001193125-25-256406.md) | [11.0 d](/filings/0001193125-26-029438.md) | [(25.9) d](/filings/0001193125-26-191644.md) | [36.5 d](/filings/0001193125-26-356919.md) | [32.1](/filings/0001193125-26-436164.md) | [62.5 d](/filings/0001193125-26-029438.md) | [0.2 d](/filings/0001193125-26-191644.md) | [29.0 d](/filings/0001193125-26-356919.md) | [10.6](/filings/0001193125-26-436164.md) |
| Capital expenditure | $m | [4.9 d](/filings/0000950170-25-010565.md) | [6.6 d](/filings/0000950170-25-061074.md) | [10.8 d](/filings/0001193125-26-356919.md) | [11.9](/filings/0001193125-25-256406.md) | [13.6 d](/filings/0001193125-26-029438.md) | [11.7 d](/filings/0001193125-26-191644.md) | [13.5 d](/filings/0001193125-26-356919.md) | [24.9](/filings/0001193125-26-436164.md) | [22.4 d](/filings/0001193125-26-029438.md) | [21.7 d](/filings/0001193125-26-191644.md) | [19.1 d](/filings/0001193125-26-356919.md) | [8.7](/filings/0001193125-26-436164.md) |
| Dividends paid | $m | [0.0 d](/filings/0000950170-25-010565.md) | [0.0 d](/filings/0000950170-25-061074.md) | [11.6 d](/filings/0001193125-26-356919.md) | [24.4](/filings/0001193125-25-256406.md) | [0.0 d](/filings/0001193125-26-029438.md) | [0.0 d](/filings/0001193125-26-191644.md) | [0.0 d](/filings/0001193125-26-356919.md) | [17.5](/filings/0001193125-26-436164.md) | [0.0 d](/filings/0001193125-26-029438.md) | [11.7 d](/filings/0001193125-26-191644.md) | [17.6 d](/filings/0001193125-26-356919.md) | [23.4](/filings/0001193125-26-436164.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-29) | Q3 FY2023 (2023-03-30) | Q1 FY2024 (2023-09-28) | Q2 FY2024 (2023-12-28) | Q3 FY2024 (2024-03-28) | Q1 FY2025 (2024-09-26) | Q2 FY2025 (2024-12-26) | Q3 FY2025 (2025-03-27) | Q1 FY2026 (2025-09-25) | Q2 FY2026 (2025-12-25) | Q3 FY2026 (2026-03-26) | Q1 FY2027 (2026-09-24) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.6](/filings/0000950170-24-009840.md) | [11.7](/filings/0000950170-24-051300.md) | [11.7](/filings/0000950170-24-119114.md) | [11.7](/filings/0000950170-25-010565.md) | [11.7](/filings/0000950170-25-061074.md) | [11.7](/filings/0001193125-25-256406.md) | [11.7](/filings/0001193125-26-029438.md) | [11.7](/filings/0001193125-26-191644.md) | [11.7](/filings/0001193125-26-436164.md) | [11.7](/filings/0001193125-26-029438.md) | [11.8](/filings/0001193125-26-191644.md) | [11.8](/filings/0001193125-26-436164.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,121,180 at 2012-05-01, from the cover of the [10-Q filed 2012-05-01](/filings/0001193125-12-201216.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 09:31 ET. No prices; not investment advice.